ArticleCancer immunology, immunotherapy : CII2026
Defining alteration in bone marrow mesenchymal stem cells (MSC) from acute myeloid leukemia and exploring cultured MSC-conditioned media as a novel anti-leukemia therapy agent.
Manasi Nagare et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.